Skip to content
Home
About Us
Company overview
Corporate culture
Licensure & Certificates
Products
Leukemia
Lymphoma
Transplant typing
Solid tumor detection
Pharmacogenomics
Pathogen detection
Cervical cancer products
Research products
Services
Platforms
Fluorescent quantitative PCR technology
First generation Sanger sequencing
Next-generation high-throughput sequencing
Capillary electrophoresis fragment analysis
Visualized molecular pathology
Microfluidics
Join Us
Talent philosophy
Recruitment
Contact Us
News
Contact Us
中文
GENOMEPRECISION
Home
About Us
Company overview
Corporate culture
Licensure & Certificates
Products
Leukemia
Lymphoma
Transplant typing
Solid tumor detection
Pharmacogenomics
Pathogen detection
Cervical cancer products
Research products
Services
Platforms
Fluorescent quantitative PCR technology
First generation Sanger sequencing
Next-generation high-throughput sequencing
Capillary electrophoresis fragment analysis
Visualized molecular pathology
Microfluidics
Join Us
Talent philosophy
Recruitment
Contact Us
News
Contact Us
中文
April 24, 2017
GenomePrecision and Exacticon Diagnostics reached strategic cooperation
On April 21, 2017, GenomePrecision and Exacticon Diagnostics signed an agreement of strategic cooperation in Beijing. […]
April 24, 2017
Read More
